With promising mid-stage trial results, berobenatide aims to make obesity treatment more convenient without compromising ...

The pharmaceutical company's flagship anti-obesity drug continues to bolster its efficacy and tolerability arguments.

The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this ...

Obesity has become a growing concern worldwide, and GLP-1 drugs have brought relief to millions struggling with weight ...

Pfizer's experimental drug, berobenatide, is designed to stay attached longer to a blood protein called albumin, helping prevent it from breaking down too quickly.

Pfizer hasn't yet tapped into the highly lucrative market of diabetes drugs that have been increasingly used for weight loss purposes. Searching for a weight-loss drug but don't like the idea of an ...

An oral drug from Pfizer causes a similar amount of weight loss as the blockbuster Ozempic injection, made by rival Novo Nordisk, according to results from a phase two clinical trial. The results were ...